Literature DB >> 18374984

Molecular characterization of Complement Factor I deficiency in two Spanish families.

Isabel María Ponce-Castro1, Carolina González-Rubio, Eva María Delgado-Cerviño, Cynthia Abarrategui-Garrido, Gumersindo Fontán, Pilar Sánchez-Corral, Margarita López-Trascasa.   

Abstract

Complement Factor I (CFI) is a regulator of the classical and alternative pathways. CFI has enzymatic activity and is able to cleave C3b and C4b. Homozygous Factor I deficiency is associated with infectious and/or autoimmune diseases. Here we describe the biochemical and genetic characterization in two Spanish families with complete Factor I deficiency. In Family 1, the propositus suffered from several episodes of meningitis for more than a year. Biochemical complement studies showed undetectable Factor I levels in the propositus and in her sister, while their parents and a brother had partial Factor I deficiency and were healthy. In Family 2, three out of five children were homozygous for Factor I deficiency, two of whom suffered from meningitis and the third one from several infections. The parents and the other two siblings were healthy and heterozygous for Factor I deficiency. Molecular studies showed that the two families had different mutations at exon 5 of the Factor I gene, which codifies for module LDLr1. One mutation corresponds to a 772G>A change at the donor splice site that was originally found in a family from Northern England. The second is a new missense mutation 739T>G, that generates a Cys to Gly change.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374984     DOI: 10.1016/j.molimm.2008.02.008

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

1.  Early Versus Late Diagnosis of Complement Factor I Deficiency: Clinical Consequences Illustrated in Two Families with Novel Homozygous CFI Mutations.

Authors:  Clara Franco-Jarava; Elena Álvarez de la Campa; Xavier Solanich; Francisco Morandeira-Rego; Virgínia Mas-Bosch; Marina García-Prat; Xavier de la Cruz; Andrea Martín-Nalda; Pere Soler-Palacín; Manuel Hernández-González; Roger Colobran
Journal:  J Clin Immunol       Date:  2017-09-23       Impact factor: 8.317

2.  Complement Factor I Variants in Complement-Mediated Renal Diseases.

Authors:  Yuzhou Zhang; Renee X Goodfellow; Nicolo Ghiringhelli Borsa; Hannah C Dunlop; Stephen A Presti; Nicole C Meyer; Dingwu Shao; Sarah M Roberts; Michael B Jones; Gabriella R Pitcher; Amanda O Taylor; Carla M Nester; Richard J H Smith
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

Review 3.  aHUS caused by complement dysregulation: new therapies on the horizon.

Authors:  Aoife M Waters; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2010-06-18       Impact factor: 3.714

Review 4.  Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis.

Authors:  Lori Broderick; Chhavi Gandhi; James L Mueller; Christopher D Putnam; Katayoon Shayan; Patricia C Giclas; Karin S Peterson; Seema S Aceves; Robert M Sheets; Bradley M Peterson; Robert O Newbury; Hal M Hoffman; John F Bastian
Journal:  J Clin Immunol       Date:  2012-08-29       Impact factor: 8.317

5.  Complete factor I deficiency due to dysfunctional factor I with recurrent aseptic meningo-encephalitis.

Authors:  Filomeen Haerynck; Patrick Stordeur; Johan Vandewalle; Rudy Van Coster; Victoria Bordon; Frans De Baets; Petra Schelstraete; Cédric Javaux; Marie-Rose Bouvry; Véronique Fremeaux-Bacchi; Joke Dehoorne
Journal:  J Clin Immunol       Date:  2013-10-20       Impact factor: 8.317

6.  Complement factor I deficiency: a not so rare immune defect: characterization of new mutations and the first large gene deletion.

Authors:  María Alba-Domínguez; Alberto López-Lera; Sofía Garrido; Pilar Nozal; Ignacio González-Granado; Josefa Melero; Pere Soler-Palacín; Carmen Cámara; Margarita López-Trascasa
Journal:  Orphanet J Rare Dis       Date:  2012-06-18       Impact factor: 4.123

7.  Classical and Non-classical Presentations of Complement Factor I Deficiency: Two Contrasting Cases Diagnosed via Genetic and Genomic Methods.

Authors:  Adrian M Shields; Alistair T Pagnamenta; Andrew J Pollard; Jenny C Taylor; Holger Allroggen; Smita Y Patel
Journal:  Front Immunol       Date:  2019-06-07       Impact factor: 7.561

8.  Prevalence and phenotype associations of complement factor I mutations in geographic atrophy.

Authors:  Adnan H Khan; Janice Sutton; Angela J Cree; Samir Khandhadia; Gabriella De Salvo; John Tobin; Priya Prakash; Rashi Arora; Winfried Amoaku; Peter Charbel Issa; Robert E MacLaren; Paul N Bishop; Tunde Peto; Quresh Mohamed; David H Steel; Sobha Sivaprasad; Clare Bailey; Geeta Menon; David Kavanagh; Andrew J Lotery
Journal:  Hum Mutat       Date:  2021-06-29       Impact factor: 4.700

9.  Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I.

Authors:  Sira Nanthapisal; Despina Eleftheriou; Kimberly Gilmour; Valentina Leone; Radhika Ramnath; Ebun Omoyinmi; Ying Hong; Nigel Klein; Paul A Brogan
Journal:  Front Immunol       Date:  2018-04-11       Impact factor: 7.561

10.  Effect of rare coding variants in the CFI gene on Factor I expression levels.

Authors:  Sarah de Jong; Elena B Volokhina; Anita de Breuk; Sara C Nilsson; Eiko K de Jong; Nicole C A J van der Kar; Bjorn Bakker; Carel B Hoyng; Lambert P van den Heuvel; Anna M Blom; Anneke I den Hollander
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.